Lifecycle
The lifecycle view presents a chronological timeline of all significant regulatory events across the portfolio. Submission dates, approval milestones, variation filings, and renewal deadlines are consolidated here. Select an application to view its complete lifecycle history.
Application Lifecycle Events
PMDA-2022-0023 — Upadacitimab
In ProgressApproved: 2023-06-22
HSA-2023-0072 — Respiralimab
FailedApproved: 2022-11-05
EMA-2023-0002 — Verasenib
Approved
PMDA-2022-0043 — Tiotropizone
Pending
TITCK-2024-0076 — Retinavab
Pending
ANMAT-2020-0075 — Haemoferrin
ActiveApproved: 2023-10-17
SFDA-2023-0097 — Neuravastatin
CompletedApproved: 2023-10-17
FDA-2024-0041 — Infectivir
ActiveApproved: 2022-08-16
ANVISA-2020-0025 — Tisagenlecleux-B
Completed
SAHPRA-2022-0098 — Alzabistat
PendingApproved: 2024-09-01
CDSCO-2022-0033 — Cardilostat
ActiveApproved: 2023-01-18
MOH-IL-2020-0040 — Fabrizyme-β
Failed
TGA-2023-0087 — Lecanemabix
Failed
EMA-2023-0042 — Respiralimab
BlockedApproved: 2024-02-20
ANVISA-2020-0005 — Immunovant-α
Active
COFEPRIS-2021-0014 — Glucovantib
PendingApproved: 2023-05-27
NMPA-2021-0084 — Semaglutidex
Draft
PMDA-2022-0063 — Cardilostat
PendingApproved: 2024-01-16
COFEPRIS-2021-0094 — Neprilozone
BlockedApproved: 2022-09-04
TGA-2023-0047 — Thymosilib
Completed
SFDA-2023-0057 — Lecanemabix
In ProgressApproved: 2024-06-21
EMA-2023-0082 — Sacubitrivex
BlockedApproved: 2023-04-06
HSA-2023-0032 — Verasenib
DraftApproved: 2023-02-18
EMA-2023-0022 — Sacubitrivex
Blocked
SAHPRA-2022-0018 — Pancrelipaze-R
SubmittedApproved: 2023-03-30
TGA-2023-0027 — Lecanemabix
BlockedApproved: 2022-12-05
ANMAT-2020-0035 — Immunovant-α
Active
MOH-IL-2020-0060 — Mavacamtamex
FailedApproved: 2022-08-03
TITCK-2024-0056 — Ozanemolistat
Approved
SAHPRA-2022-0038 — Alzabistat
Submitted